Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$15.4 - $20.16 $70.6 Million - $92.4 Million
-4,585,293 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$18.24 - $21.45 $83.6 Million - $98.4 Million
4,585,293 New
4,585,293 $83.6 Million
Q2 2018

Aug 10, 2018

SELL
$20.16 - $24.68 $46.7 Million - $57.1 Million
-2,314,286 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$20.31 - $24.95 $142 Million - $174 Million
-6,971,257 Reduced 75.08%
2,314,286 $49.1 Million
Q4 2017

Feb 12, 2018

SELL
$20.99 - $23.89 $27.9 Million - $31.7 Million
-1,327,213 Reduced 12.51%
9,285,543 $213 Million
Q3 2017

Nov 13, 2017

BUY
$20.07 - $21.89 $213 Million - $232 Million
10,612,756
10,612,756 $232 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.73B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.